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Abstract
Background: Iron supplementation during pregnancy prevents against low birth weight, incidence of prematurity
and postpartum hemorrhage. However, the coverage of iron supplementation is still low in Ethiopia. This study
aimed to investigate the spatial variations and associated factors of iron supplementation during pregnancy using
the 2011 national demographic and health survey data.
Methods: This study used secondary data from the 2011 Ethiopian demographic and health survey. The survey was
cross sectional and used a multistage cluster sampling procedure. A logistic regression statistical model using adjusted
odds ratio (AOR) and 95% confidence interval (CI) was used to identify the associated factors. Getis-Ord G-statistic was
used to identify high and low hotspot areas of iron tablet supplementation during pregnancy.
Results: The coverage of iron tablet supplementation was 17.1% [95%CI: (16.3–17.9)] with the highest coverage of 38.
9% [95%CI: (32.4–46.1)] in Addis Ababa followed by Tigray regional state with 33.8% [95%CI: (29.9–38.00)]. The lowest
coverage was found in Oromiya regional state at 11.9% [95%CI: (10.7–13.0)]. Multivariable analysis showed that mothers
who were aware of the Community Conversation Program had 20% [AOR = 1.2; 95% CI: (1.04–1.4)] higher odds of
taking iron tablets. The odds of taking iron tablets was 2.9 times [AOR = 2.9; 95% CI: (2.3–3.7)] higher among those who
took deworming tablets. Those mothers who attended the minimum four antenatal visits recommended by WHO
were 3.9 times [AOR = 3.9; 95% CI: (3.3–4.6)] more likely and those mothers in the age group 31–49 years were 2.9
times [AOR = 2.9; 95% CI: (1.1–7.4)] more likely to use iron tablets as compared to those mothers who did not
attend antenatal care and mothers in the age group less than 20 years. Mothers having a family size of 10 and
above had 32% [AOR = 0.68; 95% CI: (0.49–0.97)] lower odds of taking iron tablets during pregnancy. The spatial
analysis found that only northern, central and eastern parts of Ethiopia were identified as hotspots of iron
supplementation.
Conclusion: Iron supplementation use was not equally distributed in Ethiopia, with relatively higher prevalence
in Tigray, Addis Ababa and Harari regional states. Attention should be given to younger age mothers, mothers
with large family size and mothers who reside in areas with low coverage of iron tablet distribution. Promotion of
antenatal care services based on the WHO standard can be used as an intervention for improving iron
supplementation during pregnancy.
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Background
Iron is essential for blood production and a component of
hemoglobin for carrying oxygen in the blood. Iron defi-
ciency is one of the most preventable nutritional defi-
ciency diseases among women worldwide and particularly
prevalent during pregnancy [1]. During pregnancy, the
intake of iron is recommended to be 27 mg per day which
is 50% higher than required for non-pregnant women [2].
These iron requirement during pregnancy are extraordin-
arily high and cannot be fulfilled by dietary interventions
alone [3, 4]. The low bioavailability of iron combined with
high iron requirement during pregnancy especially in de-
veloping countries question extra source of iron such as
from supplement [5].
As a response to this demand, routine supplementation
of iron with folic acid is recommended by WHO for all
pregnant women [5]. Particularly where anemia preva-
lence is high, it is recommended for iron supplementation
to continue into the postpartum period to enable women
to acquire adequate stores of iron [6, 7]. Iron supplemen-
tation during pregnancy prevents low birth weight [6–8].
Most importantly, iron supplementation during the first
trimester of pregnancy among poor women improves
birth weight and lowers the incidence of prematurity [9].
Iron supplementation is also associated with reducing the
risk of postpartum hemorrhage [10]. As a result, daily oral
iron and folic acid supplementation is recommended as
part of antenatal care to reduce the risk of low birth
weight, maternal anemia and iron deficiency [5]. The
current recommendation is a 6 month regimen of a daily
supplement containing 60 mg of elemental iron along
with 400 mcg of folic acid [11].
In Ethiopia, the coverage of iron supplementation during
pregnancy is still low and has not fulfilled the WHO stand-
ard recommendations. This study aimed to investigate the
differences in spatial distributions of iron supplementation
and associated factors among pregnant women in Ethiopia
using the 2011 demographic and health survey data.
Methods
Study setting
The 2011 Ethiopian Demographic and Health Survey
(EDHS) was conducted in nine regional states of
Ethiopia namely; Tigray, Afar, Amhara, Oromia, Somali,
Benishangul-Gumuz, Southern Nations Nationalities and
Peoples (SNNP), Gambella and Harari and two city Ad-
ministrations (Addis Ababa and Dire Dawa). Ethiopia is
one of the sub-Saharan countries found in the Horn of
Africa with 73.5 million with a populations of according
to 2007 national housing and population census [12].
Data type and study design
Data for this analysis was taken from the 2011 Ethiopian
Demographic and Health Survey (EDHS 2011). The
sample for the survey was designed to represent na-
tional, urban–rural, and regional estimates of health and
demographic outcomes. The 2011 EDHS samples were
selected using a stratified, two-stage cluster sampling
design. In the first stage, 624 clusters of census enumer-
ation areas (EAs), 187 in urban and 437 in rural areas
were included in the survey. In the second stage, a
complete listing of households was carried out in each
of the 624 selected EAs from September 2010 through
January 2011. Sketch maps were drawn for each of the
clusters, and all conventional households were listed. A
representative sample of 17,817 households was selected
for the 2011 EDHS. Subsequently a total of 16,515
women in the age group 15–49 years who were usual
residents or who slept in the selected households the
night before the survey were eligible and interviewed for
the survey. Among those women interviewed, 7764 were
pregnant mothers who had pregnancy in the preceding
5 years [13, 14].
For this analysis, information on a wide-range of poten-
tial independent variables including socio-demographic,
economic variables and health service related factors and
iron supplementation during pregnancy as a dependent
variable were extracted from the DHS data warehouse for
7764 pregnant mothers. Educational status of women and
partner, birth interval, family size, age of the women, par-
ity, occupation (working vs not working), residence (urban
vs rural) and region where the respondent reside were the
socio-demographic variables extracted from the data set
for this study. Wealth index was used to measure the
socio-economic status, to indicate inequalities in house-
hold characteristics. The index constructed serves as an
indicator of level of wealth that is consistent with expend-
iture and income measures. Wealth index was constructed
using household asset data via principal components ana-
lysis to categorize individuals into wealth quintile (poorest,
poorer, medium, richer and richest). Variables included in
the construction of the wealth index were ownership of
selected household assets, size of agricultural land, quan-
tity of livestock and materials used for house construction
[14]. Health service related factors such as antenatal care
attendance for the indexed pregnancy, anemia status
(anemic vs non anemic), deworming tablet intake during
the indexed pregnancy (yes or no), mass media exposure
(exposure to mass media (indexed from television, news-
paper and radio), awareness of Community Conversation
(CC) program were extracted. Community Conversation
is a health information delivery program which is imple-
mented in rural communities of Ethiopia to improve the
awareness of the community on different topics such as
ANC, pregnancy and nutrition. The community members
discuss each other on different issues of health with guid-
ance from the community health workers (health exten-
sion worker). The discussion sometimes might be
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moderated by health development army, who serve as an
assistant for the community health worker. The iron sup-
plementation was collected from self-reported by showing
the iron tablet by asking “During this pregnancy, were you
given or did you buy any iron tablets? In this study, we
used ever use of iron tablet as a dependent variable.
Spatial analysis
Spatial analysis was applied to detect geographic variation
among EDHS clusters through the application of Geo-
graphic Information System (GIS), an ArcGIS software of
version 10.0 produced by ESRI, Redlands, CA, USA. The
GPS points were downloaded with permission from Meas-
ure DHS and merged with the coverage of iron supple-
mentation in each DHS study clusters. The coverage of
iron tablet supplementation during pregnancy was
exported into ArcGIS to visualize clusters of hot and low
spots. Spatial heterogeneity of significant high coverage or
low coverage of iron tablet supplementation were com-
puted for each cluster using the Getis-Ord G-statistic tool
in ArcGIS. To determine the significance of these sta-
tistics, Z-scores and P-value were used. A z-score near
zero indicates no apparent clustering within the study
area. A positive z-score with P-value of <0.05 indicates
clustering of statistically high hotspots of iron supple-
mentation, whereas a negative z-score with p-value of
<0.05 indicates clustering of statistically low spots of
iron supplementation. Maps to show the distribution
and variations of iron supplementation throughout the
country were constructed.
Statistical analysis
Descriptive statistics including prevalence and frequency
distributions were used to determine the level of iron
supplementation. Bivariate analysis was used to show
the association between socio-demographic characteris-
tics and iron tablet use. Variables that were determined
statistically significant at p-value <0.25 during bivariate
analysis were considered for adjustment in the level of
multivariable logistic regression model [15, 16]. This cut-
off point prevented removing variables that would
potentially have an effect during multivariable analysis.
A stepwise approach was used to assess the iteration of
variables and to control potential confounders [17]. We
had checked the model by entering different variables
step by step. The model with high value of iteration was
selected as our final model in the multivariable logistic
regression. In the multivariable model, odds ratio with
95% CI was used. A multi-collinearity test was done and
as a result no variables had collinearity with variance
inflation factors (VIF) of greater than 10 [18]. Sample
weights were applied in order to compensate for the un-
equal probability of selection between the strata that were
geographically defined as well as for non-responses. A
detailed explanation of the weighting procedure can be
found in the 2011 EDHS [19]. The “svy” command in
STATA version 11 (Stata Corporation, College Station,
TX, USA) was used to weight the survey data.
Results
The overall coverage of iron supplementation was 17.1%
with [95%CI: (16.3–17.9)]. The highest coverage of iron
tablet intake during pregnancy was found in Addis
Ababa at 38.9% [95% CI: (32.4–46.1)], followed by
Tigray regional state with 33.8% [95% CI (29.9–37.9)].
As shown on Fig. 1, the coverage of iron supplementa-
tion reaches up to 46 to 86% in certain geographic clus-
ters particularly in the northern, central, eastern and
western parts of the country. There are also some clus-
ters with coverage of iron supplementation during preg-
nancy from 27.3 to 43.4% in few clusters all over the
country. There were also a few numbers of clusters who
had iron supplementation coverage from 11.8 to 27.3%.
There were no EDHS clusters (enumeration areas)
included in the peripheral eastern parts of the country,
particularly in Somalia region, unable to estimate the
coverage.
The Getis-Ord G-statistic showed that iron supple-
mentation during pregnancy was not uniform in
Ethiopia. Figure 2 showed the spatial variation of iron
supplementation during pregnancy at the cluster level
(lower level). The analysis at the cluster level shows that
statistically significant high hot-spots of iron tablet
intake during pregnancy were found in Tigray region,
northern parts of the country, Addis Ababa, Central
Ethiopia, and Harar and Dire Dawa, Eastern Ethiopia
whereas statistically significant low spots of iron intake
during pregnancy were found in most part of the coun-
try i.e. the Northern Ethiopia (Amhara region, and few
clusters of Benshangul-Gumuz and Affar region), most
parts of Oromiya region, South nation, nationalities and
people Region, South west Ethiopia (few clusters of
Gambella region) (Fig. 2).
The lowest coverage was found in Oromiya region at
11.9% [95% CI: (10.7–13.0)]. The coverage of iron intake in
urban settings was found to be 27.3% [95% CI: (24.8–29.9)].
About 23% [95% CI: (21.9–25.0)] of pregnant mothers from
the rich wealth tertile had received iron tablet supplementa-
tion during their last pregnancy. Similarly the coverage of
iron supplementation was 35.6% [95% CI: (30.8–40.66)]
and 28.0% [95% CI: (24.8–31.3)] among mothers who had
at least secondary education and mothers who had husband
with a secondary education level and above, respectively
(Table 1).
Variables including wealth index, residence, maternal
education, husband education, Community Conversation
(CC), deworming tablet intake, antenatal care attend-
ance, age, anemia status, birth interval, occupation,
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Fig. 1 Iron intake during pregnancy spatial distribution in Ethiopia, 2011
Fig. 2 Map to display hot and cold spot clusters of iron supplementation during pregnancy in Ethiopia, 2011
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family size and mass media were found to have statisti-
cally significant associations with iron tablet intake at p-
value <0.25, a cutoff point determined at bivariate ana-
lysis stage. Parity was not significantly associated at p-
value 0.25 in the bivariate stage.
In the final multivariable model, awareness of
Community Conversation (CC) program, deworming
tablet intake, ANC attendance, mother’s age and family
size were significantly associated with iron tablet intake
during pregnancy. Those mothers who were aware of the
CC program had 20% [AOR= 1.2; 95% CI: (1.01–1.40)]
higher odds of taking iron tablets as compared with
mothers who had no CC program awareness. The odds of
taking iron tablets were 2.9 times (AOR = 2.9; 95% CI:
(2.3–3.7) higher among those who took deworming tab-
lets. Those mothers who attended the minimum four
ANC visits as recommended by WHO were nearly 4 times
[AOR = 3.9; 95% CI: (3.3–4.6)] more likely to take iron
tablets as compared to those who did not attended the
minimum recommended ANC visits. The odds of taking
Table 1 Iron supplementation during pregnancy by











Tigray 526 8.1 33.8 (29.9–38.00)
Afar 78 1.2 23.4 (14.9–33.8)
Amhara 1984 30.5 19.1 (17.4–20.8)
Oromia 3109 47.8 11.9 (10.7–13.0)
Somali 197 3.0 20.0 (14.7–25.8)
Benshangul-gumz 92 1.4 23.4 (15.2–31.8)
SNNPR 246 3.8 15.1 (13.4–16.9)
Gambella 31 0.5 27.5 (12.8–43.2)
Harari 19 0.3 31.6 (13.9–54.5)
Addis Ababa 192 3.0 38.9 (32.4–46.1)
Dire Dawa 26 0.4 28.2 (12.6–46.1)
Residence
Urban 1183 15.0 27.3 (24.8–29.9)
Rural 6,699 85.0 15.3 (14.4–16.2)
Wealth index
Poor 3420 43.4 13.0 (12.0–14.2)
Middle 1622 20.6 15.2 (13.5–17.0)
Rich 2840 36.0 23.1 (21.9–25.0)
Current occupation status
Not working 3499 44.4 15.6 (14.4–16.8)
Working* 4383 55.6 18.3 (17.2–19.4)
Religion
Christian 5157 65.4 17.9 (16.9–19.0)
Muslim 2552 32.4 15.9 (14.5–17.4)
Others 173 2.2 9.2 (5.6–14.3)
Community conversation
Not heard 878 30.4 15.0 (14.1–15.9)
Heard 2008 69.6 23.3 (21.5–25.2)
Mother education
None 5249 66.6 14.9 (13.9–15.9)
Primary 2266 28.6 19.2 (17.6–20.8)
Secondary and higher 368 4.7 35.6 (30.8–40.6)
Husband education
None 3847 49.7 14.1 (13.0–15.2)
Primary 3171 40.9 17.9 (16.6–19.3)
Secondary and higher 729 9.4 28.0 (24.8–31.3)
ANC use
0–3 times 6350 80.6 12.0 (11.2–12.8)
4+ times 1553 19.4 38.1 (35.6–40.6)
Anemia status
Table 1 Iron supplementation during pregnancy by
background characteristics in Ethiopia, 2011 (Continued)
Anemic 1429 18.8 14.5 (12.7–16.4)
Not anemic 6181 81.2 18.0 (17.1–19.0)
Parity
1–4 4849 61.5 17.1 (16.1–18.2)
5–9 2703 34.3 17.1 (15.8–18.6)
10+ 330 4.2 15.8 (12.1–20.0)
Taking Deworming tablet
No 7393 94.4 15.6 (14.8–16.4)
Yes 435 5.6 39.8 (35.3–44.4)
Age of the mother
< 20 years 402 5.1 8.2 (5.8–11.2)
20–30 years 4598 58.3 17.4 (16.4–18.6)
31–49 years 2883 36.6 17.7 (16.4–19.2)
Birth interval
≤ 2 years 1017 15.7 16.00 (13.9–18.4)
2–3 years 2409 37.2 14.9 (13.5–16.3)
≥ 3 years 3048 47.1 18.8 (17.4–20.2)
Family size
1–4 2267 28.8 18.4 (16.9–20.1)
5–9 5138 65.2 16.7 (15.7–17.74)
10+ 478 6.1 14.8 (11.9–18.3)
Mass media exposure
Have no exposure 3157 40.1 12.8 (11.6–14.06)
Have exposure 4708 59.9 20.0 (18.9–21.25)
Total 7883 17.08 (16.3–17.9)
*Any professional/technical/managerial, clerical, sales and services, skilled manual,
unskilled manual and agriculture classifications were classified as working
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iron supplements during pregnancy were nearly 3 times
[AOR = 2.9; 95% CI: (1.1–7.4)] higher among those
mothers who were in the age group 31–49 years as com-
pared to those mothers who were in the age group <
20 years. The odds of taking iron tablets during pregnancy
were lower among those with larger family size. Those
mothers with family size ≥ 10 had 32% [AOR= 0.68; 95%
CI: (0.49–0.97)] lower odds of iron tablet intake during
pregnancy (Table 2).
Discussion
During pregnancy, the physiological requirement of iron
is one of the public health difficulties to meet with most
diets in developing countries [2–4, 20]. Pregnant women
should routinely receive iron supplements in almost all
contexts [21]. However, the coverage of iron supplemen-
tation during pregnancy remains low in Ethiopia. Only
17.1% of the pregnant mothers in this study took iron
supplements. The geospatial analysis showed that Tigray,
Addis Ababa and Harari regional states were statistically
significant hot spot areas for iron supplementation dur-
ing pregnancy. A possible justification could be because
Addis Ababa and Harari are urban areas. Thus access to
awareness of the iron supplementation program and its
benefits might be better than in other geographic areas.
The cold spot clusters are concentrated in Amhara
region, particularly in the northwestern part of the re-
gion, central Oromiya, South nation, nationalities and
people regional state of Ethiopia. The probable justifica-
tion could be the antenatal coverage was low as com-
pared to the hotspot areas [13]. ANC is the major
modality to distribute iron tablet for pregnant mothers
in Ethiopia. This study also found that those mothers
who had attended the ANC had higher odds to receive
iron tablet as compared to their counter parts. The na-
tional coverage of iron supplementation is lower as com-
pared to available studies from Pakistan [22] and
Tanzania [23].
A finding from a qualitative study done on health profes-
sionals in Southern Nation and Nationalities People state
(SNNP) and Tigray regional states revealed that even
though they are aware of the guideline, the practice in most
health posts has been to distribute Iron folic acid (IFA) on a
curative basis only to anemic women [24]. There was also
poor understanding of the benefits of iron folic acid supple-
ments for non-anemic pregnant women or their infants,
particularly for seemingly healthy pregnant women. Add-
itionally, there are some negative perceptions about iron
and folic acid supplements (i.e. that they might make the
baby bigger, or that they are bad for the baby) [24]. A study
from North West Amhara in Ethiopia revealed that 28.5%
of women believed that continuous uptake of iron folate
supplementation leads to over-weight babies [25], which
misleads mothers not to use iron supplements.
Having WHO minimum ANC attendance (at least
four times) was associated with higher intake of iron
tablets during pregnancy. Other studies have also re-
ported that a higher number of ANC visits was associ-
ated with iron tablet use during pregnancy [22, 26]. In
addition to the basic fact that more ANC visits means
more interaction with a health provider, this could be
due to the fact that when mothers attended ANC fre-
quently, their hemoglobin level could be monitored con-
tinuously Pregnant women should routinely receive
information on the signs of complications and be tested
for them at all antenatal care visits. This helps the
mother to receive iron tablet based on their hemoglobin
progress.
Community Conversation (CC) is one of the programs
implemented in rural communities of Ethiopia to com-
municate health information on different topics such as
ANC, pregnancy and nutrition. In this study, those
mothers who were aware of the CC program were more
likely to receive iron tablets during pregnancy. The com-
munity conversation might help mothers to be aware of
the advantages of taking iron tablets during pregnancy
and ANC attendance. Women who were aware of the
CC program would have a positive understanding of the
benefits of taking iron tablets. A study from North West
Amhara showed that those mothers who had good
Table 2 Binary and multivariable logistic regression to identify
factors associated with iron intake during pregnancy in Ethiopia,
2011




Aware of CC program
No 1.0 1.0
Yes 1.7 (1.5–2.0) 1.2 (1.04–1.4)**
Deworming tablet intake
No 1.0 1.0
Yes 3.6 (2.9–4.4) 2.9 (2.3–3.7)*
ANC attendance
< 4 times 1.0 1.0
≥ 4 times 4.5 (4.0–5.1) 3.9 (3.3–4.6)*
Maternal age
< 20 1.0 1.0
20–30 2.4 (1.6–3.4) 2.5 (1.0–6.3)
31–49 2.4 (1.7–3.5) 2.9 (1.1–7.4)**
Family Size
< 4 1.0 1.0
5–9 0.9 (0.8–1.0) 0.9 (0.8–1.1)
10+ 0.8 (0.6–1.0) 0.7 (0.5–0.97)**
*p < 0.05, **p < 0.001
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knowledge were more likely to be compliant with rec-
ommendation for iron tablet intake during their preg-
nancy compared to those who had low knowledge [25].
In this analysis, older maternal age was significantly
associated with higher odds of taking iron tablets during
pregnancy. This is consistent with a study from
Tanzania, India and Sudan [23, 25, 27, 28]. The possible
explanation could be that older mothers assume at
greater risk for anemia due to repeated pregnancy and
supplemented iron for preventing anemia. Older women
may also be more concerned about their health and
pregnancy outcomes, receive necessary support and co-
operation from their family members and have had more
better experience in prevention and treatment of iron
deficiency anemia [25]. Public health messages may not
have effectively reached younger age groups.
In this study, pregnant mothers who took deworming
tablets had higher odds of taking iron tablets during
pregnancy. In populations with endemic hookworm,
anti-helminthic therapy should be given presumptively
to anyone with severe anemia, because treatment is safe
and much less expensive than diagnosing hookworm
infection [21, 28]. Interaction with health workers for
deworming tablets would increase pregnant women’s up-
take of recommended iron tablets. Those mothers from
households with a larger family size (≥10) were less
likely to receive iron tablets during pregnancy. This
could be due to the fact that those mothers might attend
less ANC due to higher burdens of responsibility in their
households to care for multiple family members including
children.
This study has limitations. This is a secondary data
analysis which missed key variables that potentially de-
termine iron supplementation use during pregnancy in a
wider perspective. Potential explanatory variables such
as availability of iron tablet in the health institution and
knowledge of pregnant mothers were not assessed. Some
regions had small sample size, which questions the ac-
curacy of coverage estimates per region, so that it should
be interpreted in caution.
Conclusion
Differences in iron supplementation use during pregnancy
was observed in Ethiopia with relatively higher coverage
of iron supplementation areas found in Northern eastern
Tigray, central Ethiopia near Addis Ababa and Eastern
parts of Ethiopia near Dire Dawa and Harari. Attention
should be given to mothers of younger age and those with
large family size. Promotion of ANC services based on the
WHO standard can be used as an intervention for im-
proving iron supplementation during pregnancy.
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